Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Cohen

Showing results (11-20 of 867) with videos related to

Pageof 87
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 8, 2010
Drug coverage for transplantation turns into political football: big business trumps patientsDavid J Cohen, Barbara Murphy
Journal of the American College of Cardiology|March 7, 2026
When the Curve Bends: Low-Risk TAVR Beyond Year 5Aakriti Gupta, David J Cohen
JACC. Cardiovascular Interventions|May 29, 2024
Myocardial Infarction After TAVR: Much Ado About Nothing?David J Cohen, Wally Omar
Zeitschrift Fur Kardiologie|March 19, 2003
Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stentDan Greenberg, David J Cohen
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 23, 2007
Drug-eluting stentsDavid J Cohen, Ameet Bakhai
Circulation|October 18, 2006
Are drug-eluting stents cost-effective? It depends on whom you askJason Ryan, David J Cohen
Circulation. Cardiovascular Quality and Outcomes|May 18, 2021
Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not "All About the Benjamins"Khanjan B Shah, David J Cohen
American Heart Journal|May 8, 2004
Does stenting save lives? Understanding the strengths and limitations of meta-analysisAdhir R Shroff, David J Cohen
JAMA Cardiology|June 21, 2023
Evidence Generation for Novel Cardiovascular Devices-Putting the Horse Back in Front of the CartDavid J Cohen, Manesh R Patel
Journal of the American College of Cardiology|January 5, 2013
Reply: To PMID 22818074Matthew R Reynolds, David J Cohen
Pageof 87

Showing results (11-20 of 867) with videos related to

Sort By:
Pageof 87
Clinical Journal of the American Society of Nephrology : CJASN|May 8, 2010
Drug coverage for transplantation turns into political football: big business trumps patientsDavid J Cohen, Barbara Murphy
Journal of the American College of Cardiology|March 7, 2026
When the Curve Bends: Low-Risk TAVR Beyond Year 5Aakriti Gupta, David J Cohen
JACC. Cardiovascular Interventions|May 29, 2024
Myocardial Infarction After TAVR: Much Ado About Nothing?David J Cohen, Wally Omar
Zeitschrift Fur Kardiologie|March 19, 2003
Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stentDan Greenberg, David J Cohen
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 23, 2007
Drug-eluting stentsDavid J Cohen, Ameet Bakhai
Circulation|October 18, 2006
Are drug-eluting stents cost-effective? It depends on whom you askJason Ryan, David J Cohen
Circulation. Cardiovascular Quality and Outcomes|May 18, 2021
Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not "All About the Benjamins"Khanjan B Shah, David J Cohen
American Heart Journal|May 8, 2004
Does stenting save lives? Understanding the strengths and limitations of meta-analysisAdhir R Shroff, David J Cohen
JAMA Cardiology|June 21, 2023
Evidence Generation for Novel Cardiovascular Devices-Putting the Horse Back in Front of the CartDavid J Cohen, Manesh R Patel
Journal of the American College of Cardiology|January 5, 2013
Reply: To PMID 22818074Matthew R Reynolds, David J Cohen
Pageof 87